Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
1999 R43 PAR-98-066 GOLDRICK, MARIANNA M AMBION, INC. DETECTION AND QUANTITATION OF FUSION MRNAS IN LEUKEMIA Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2018 R43 PAR-18-303 LEE, LY JAMES NANOMATERIAL INNOVATION, LTD Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis Complete
1999 R43 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2017 R43 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2000 R43 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2018 R43 PAR-18-303 SCHOETTLE, LOUIS GEMNEO BIOSCIENCE, INC. Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes Complete
1999 R43 PAR-98-066 WIKTOR, PETER J. ENGINEERING ARTS PIEZO ELECTRIC PIPETTING TECHNOLOGY FOR DNA ANALYSIS Complete
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2000 R43 PAR-99-101 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DISCRETE ASSAY FOR INTEGRATED HPV DNA IN CERVICAL CELLS Complete
2019 R43 PAR-18-303 KHODAVERDIAN, VARANDT Y. NUPROBE USA, INC. Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing Complete
1999 R43 PAR-98-066 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2000 R43 PAR-99-101 CHO, RAYMOND JAIHYUN INGENUITY SYSTEMS, INC. FUNCTIONAL CLUSTERING APPROACH TO GENOMIC ANALYSIS Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CHEE, MARK S. ILLUMINA, INC. PARALLEL ARRAY PROCESSOR Complete
2005 R43 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete
2019 R43 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
1999 R43 PAR-98-066 BEACH, DAVID H. GENETICA, INC. TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS Complete
2005 R43 RFA-CA-05-006 LU, CHIUNG-MEI GENACO BIOMEDICAL PRODUCTS, INC. EXPRESSION PROFILING OF MICRORNAS WITH BEAD ARRAY Complete
2019 R43 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
1999 R43 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2005 R43 RFA-CA-05-006 MOEN, PHILLIP T ONE CELL SYSTEMS, INC DETECTING INTEGRATED HPV DNA IN IMMUNOCOMPROMISED WOMEN Complete
2008 R43 RFA-CA-07-039 TYRRELL, STEVEN PATRICK CONTROLLED PROCESS TECHNOLOGIES, LLC A RAPID SOLUTION-PHASE IMMUNOASSAY FOR PROTEOMICS Complete
2005 R43 RFA-CA-05-006 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2008 R43 RFA-CA-07-043 PAMULA, VAMSEE K ADVANCED LIQUID LOGIC MULTIPLEXING CANCER SAMPLE PREPARATION: INDIRECT IMMUNOMAGNETIC ENRICHMENT Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2021 R43 PAR-18-303 ALLEN, JEFFREY KEITH TUMORGEN, INC. Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens. Active
2008 R43 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2008 R43 RFA-CA-07-041 CHENCHIK, ALEX CELLECTA, INC. ARRAY-ASSISTED INSERTIONAL MUTAGENESIS PLATFORM FOR FORWARD GENETICS OF CANCER Complete
2015 R43 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2006 R43 RFA-CA-06-006 BEAUDENON, SYLVIE LUCIE AMBION DIAGNOSTICS, INC. ONCOGENIC MICRORNAS IN HPV-INFECTED CERVICAL SAMPLES Complete
2008 R43 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2008 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete

Pages